TD BUY $BRKA at 307936.00, Supp 305580.00 Resis 327765.62 R7 HiLo 11% DIV N/A #Berkshire #stocks #trading #finance #market

2019-05-17
74 Views

TD BUY detected for BRKA (Berkshire Hathaway I) at the close price of 307936.00 with a support level at 305580.00 and a resistance at 327765.62, providing an opportunity for a 7 % return. Trading at a 11 % level between the 52week High (310000.00) and 52 week Low (307690.00). The average analyst 1-year target price is 0.0 with an average and a score of 0.0.

TD Buy
7 %
BRKA
307936.00
Berkshire Hathaway I
HiLo
10.6 %
Support
305580.00
Resistance
327765.62
Target1Y
0.00
Rated
Score
0.0
52week high
310000.00
52week low
307690.00
50DMA
310511.27
200DMA
310986.96
10DMA
0.00
20DMA
0.00
100DMA
0.00
Volume
159
AvgDayVol
0
MarketCap
507518550016
EBITDA
0
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
14 views
Bull, Europe, Germany
14 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
10 views
Bear, Europe, Financial Services
10 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.